Analysed CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) News Sources
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight
02-09-2026
yahoo.com
Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors
09-09-2026
yahoo.com
Will Regaining Emugrobart Rights and Refocusing on SMA Change Chugai Pharmaceutical's (TSE:4519) Narrative
05-10-2026
yahoo.com
Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances
22-10-2026
marketbeat.com
Chugai expects full-year results to beat forecast as drug exports and royalties gr
27-10-2026
yahoo.com
What is the current price of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The current price of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is $21.66.
CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) since the previous trading day is $0.51.
CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) since the previous trading day is 2.4113%.
What is the most recent average sentiment score for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The most recent average sentiment score for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The most recent sentiment for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is .
SEC-8K** Filing Available For CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.